S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
TSE:RVX

Resverlogix Corp. (RVX.TO) Stock Forecast, Price & News

C$0.96
+0.05 (+5.49 %)
(As of 03/5/2021 03:59 PM ET)
Add
Compare
Today's Range
C$0.89
Now: C$0.96
C$0.96
50-Day Range
C$0.89
MA: C$0.93
C$1.02
52-Week Range
C$0.56
Now: C$0.96
C$1.52
Volume32,125 shs
Average Volume55,352 shs
Market CapitalizationC$224.63 million
P/E Ratio53.33
Dividend YieldN/A
BetaN/A
Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.

Headlines

Resverlogix Corp. (RVX.TO)
January 30, 2021 |  uk.finance.yahoo.com
Resverlogix Reschedules Update Webcast and Conference Call
January 27, 2021 |  finance.yahoo.com
Resverlogix Announces Update Webcast and Conference Call
January 19, 2021 |  finance.yahoo.com
Zenith Confirms Interim Filings on SEDAR - Yahoo Finance
October 28, 2020 |  finance.yahoo.com
Zenith Confirms Interim Filings on SEDAR
October 28, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-403-2549252
Employees25
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC($0.23) per share

Profitability

Miscellaneous

Market CapC$224.63 million
Next Earnings Date3/12/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.72 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
C$0.96
+0.05 (+5.49 %)
(As of 03/5/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RVX News and Ratings via Email

Sign-up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Resverlogix Corp. (RVX.TO) (TSE:RVX) Frequently Asked Questions

What stocks does MarketBeat like better than Resverlogix Corp. (RVX.TO)?

Wall Street analysts have given Resverlogix Corp. (RVX.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Resverlogix Corp. (RVX.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Resverlogix Corp. (RVX.TO)'s next earnings date?

Resverlogix Corp. (RVX.TO) is scheduled to release its next quarterly earnings announcement on Friday, March 12th 2021.
View our earnings forecast for Resverlogix Corp. (RVX.TO)
.

How were Resverlogix Corp. (RVX.TO)'s earnings last quarter?

Resverlogix Corp. (RVX.TO) (TSE:RVX) released its quarterly earnings results on Monday, December, 14th. The biotechnology company reported ($0.03) EPS for the quarter.
View Resverlogix Corp. (RVX.TO)'s earnings history
.

How has Resverlogix Corp. (RVX.TO)'s stock price been impacted by Coronavirus (COVID-19)?

Resverlogix Corp. (RVX.TO)'s stock was trading at C$1.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RVX shares have decreased by 6.8% and is now trading at C$0.96.
View which stocks have been most impacted by COVID-19
.

Who are Resverlogix Corp. (RVX.TO)'s key executives?

Resverlogix Corp. (RVX.TO)'s management team includes the following people:
  • Mr. Donald J. McCaffrey, Co-Founder, Chairman, Pres, CEO & Sec.
  • Mr. Aaron Bradley Cann C.A., CPA, CA, CPA, CBV, Chief Financial Officer
  • Mr. Kenneth Eugene Lebioda BA, Sr. VP of Bus. & Corp. Devel.
  • Dr. Michael Sweeney, Sr. VP of Clinical Devel. (Age 60, Pay $525.29k)
  • Dr. Ewelina Kulikowski, Sr. VP of R&D
  • Dr. Norman C.W. Wong B.Sc., FRCPC, M.Sc., B.Sc (Hon), M.Sc, M.D., FRCP(, Co-Founder, Chief Scientific Officer & Chairman of the Scientific Advisory Board
  • Mr. Paul Moon, VP of Investor Relations & Communications
  • Sarah Zapotichny, Director of Investor Relations & Corp. Communications
  • Dr. Jan O. Johansson, Sr. VP of Medical Affairs

Who are some of Resverlogix Corp. (RVX.TO)'s key competitors?

What other stocks do shareholders of Resverlogix Corp. (RVX.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Resverlogix Corp. (RVX.TO) investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Oncolytics Biotech (ONC), (ATE), Radient Technologies (RTI), VentriPoint Diagnostics (VPT), Endocyte (ECYT), Allena Pharmaceuticals (ALNA), Catalyst Pharmaceuticals (CPRX) and Royalty Pharma (RPRX).

What is Resverlogix Corp. (RVX.TO)'s stock symbol?

Resverlogix Corp. (RVX.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "RVX."

How do I buy shares of Resverlogix Corp. (RVX.TO)?

Shares of RVX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Resverlogix Corp. (RVX.TO)'s stock price today?

One share of RVX stock can currently be purchased for approximately C$0.96.

How much money does Resverlogix Corp. (RVX.TO) make?

Resverlogix Corp. (RVX.TO) has a market capitalization of C$224.63 million.

How many employees does Resverlogix Corp. (RVX.TO) have?

Resverlogix Corp. (RVX.TO) employs 25 workers across the globe.

What is Resverlogix Corp. (RVX.TO)'s official website?

The official website for Resverlogix Corp. (RVX.TO) is www.resverlogix.com.

Where are Resverlogix Corp. (RVX.TO)'s headquarters?

Resverlogix Corp. (RVX.TO) is headquartered at 300-4820 Richard Rd SW, CALGARY, AB T3E 6L1, Canada.

How can I contact Resverlogix Corp. (RVX.TO)?

Resverlogix Corp. (RVX.TO)'s mailing address is 300-4820 Richard Rd SW, CALGARY, AB T3E 6L1, Canada. The biotechnology company can be reached via phone at +1-403-2549252.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.